It underlines our dedication to improving the lives of sufferers receiving chemotherapy. Dr Alan Smith, Vice President, Research & Advancement of Archimedes Development Ltd, the development company of Archimedes Pharma, commented: Archimedes was pleased to use our knowledge in rapidly delivering item into medical trials to facilitate the first commencement of the Granisetron Nasal Spray program. Patients suffering from severe CINV or intractable vomiting are often unable to tolerate oral medication and nasal delivery will offer such patients a real alternative.During the past decade general malaria deaths have dropped by almost 20 percent and many African countries have cut malaria instances by over 50 percent, saving the lives of 485 children every day. At the United Nations headquarters in New York this morning, Dr. Asha-Rose Migiro, Deputy Secretary-General of the United Nations, with Professor Coll-Seck together, offered UAM African and multi-nationwide corporate leaders, including Exxon Mobil, Nando’s, Novartis, Pfizer, Standard Bank, Sumitomo Chemical substance and Vestergaard Frandsen with a ‘Golden Boot’ recognizing their contribution to the fight against malaria.